ARCHIVES

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002